news Structural changes in SARS-CoV-2 Alpha and Beta variants revealed 28 June 2021 | By Victoria Rees (Drug Target Review) A study has uncovered previously unknown properties of the Spike protein from the SARS-CoV-2 Alpha and Beta variants.
news Spike protein analysis explains faster spread of SARS-CoV-2 variants 18 March 2021 | By Victoria Rees (Drug Target Review) Using cryo-electron microscopy, researchers have imaged how the SARS-CoV-2 Spike protein changes with the D614G mutation to enable faster spread of infection.
news Novel antibody-drug candidate to treat pancreatic cancer developed 10 November 2020 | By Victoria Rees (Drug Target Review) Scientists have developed a new antibody-drug conjugate (ADC), made from ICAM1, an antibody that targets pancreatic cancer and the cytotoxic drug DM1 (mertansine).
news COVID-19 research indicates SARS-CoV-2 exploits immune defences to drive infection 22 April 2020 | By Hannah Balfour (Drug Target Review) A new study has revealed that less than 10 percent of respiratory and intestinal cells are susceptible to SARS-CoV-2 infection and expression of ACE2 receptors is driven by the body's immune response.
news Using CRISPR-Cas9 to identify new gene drug targets 26 March 2020 | By Victoria Rees (Drug Target Review) Researchers have used CRISPR-Cas9 to screen the genome for possible targets that could be used in potential treatments for muscular dystrophy.
news Method to coax immune system into selecting HIV antibodies developed 9 December 2019 | By Hannah Balfour (Drug Target Review) Immunogens can be used to coax the immune system into producing broadly neutralising antibodies to fight a HIV infection, making a vaccine against the condition more likely, say researchers.
news Antibodies used to treat and reverse MS symptoms in mice 7 October 2019 | By Victoria Rees (Drug Target Review) Researchers have identified a protein on the surface of cells that cause MS and have used antibodies as an effective treatment for the condition in mice.
news Breast cancer progression may be halted with CRISPR gene editing 26 August 2019 | By Rachael Harper (Drug Target Review) A tumour-targeted CRISPR gene editing system encapsulated in a nanogel could halt the growth of triple-negative breast cancer.
news Four cell types discovered in glioblastoma tumours 12 August 2019 | By Victoria Rees (Drug Target Review) A new study has revealed that glioblastomas contain four different types of cell which the researchers say should be treated separately.
news New research advances the possibility of regenerating tissue after a heart attack 23 April 2019 | By Drug Target Review This research advances the possibility of reviving the heart's regenerative capacities using microRNAs.
news Pre-clinical testing with in vitro model may streamline vaccine development 20 November 2018 | By Drug Target Review A team of scientists have developed the first modelling system for testing age-specific human immune responses to vaccines -- outside the body...
news Early treatment could reverse autistic behaviour in tuberous sclerosis 10 October 2018 | By Drug Target Review Scientists may have found a sensitive time period where autism related social deficits could be reversed in tuberous sclerosis...
news Transparent high-resolution EEG array allows brain imaging 7 September 2018 | By Drug Target Review Researchers have developed a see-through, dual-layered, mesh EEG device which is capable of measuring the electrical activity of individual neurons...
news Scientists reverse diabetes using modified blood stem cells 16 November 2017 | By Dr Zara Kassam (Drug Target Review) Researchers have successfully reversed type 1 diabetes by infusing blood stem cells pre-treated to produce more PD-L1...
news New study links neuropilin 2 deficiency to inflammation-induced edema & lymphedema 14 October 2016 | By Niamh Louise Marriott, Digital Content Producer The Nrp2 knockout mice showed massively increased and prolonged edema following inflammation. Investigation into this finding led Bielenberg's laboratory...